[1]
J. E. van Oudtshoorn, “A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme”, J Pharm Pharm Sci, vol. 21, pp. 27–37, Mar. 2018.